New drugs delay bone metastases in prostate cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1293, 2001-01, pp. : 8-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of bone metastases in prostate cancer

Inpharma, Vol. 1, Iss. 1392, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients

Current Radiopharmaceuticals, Vol. 10, Iss. 3, 2017-11 ,pp. : 195-202

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for prostate cancer

By Siddiqui Kashif Klotz Laurence H

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 455-470

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs in prostate cancer

By Blackledge G. Sheppard A.

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 303-316

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for prostate cancer

By Chung Paul H Gayed Bishoy A Thoreson Gregory R Raj Ganesh V

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 4, 2013-12 ,pp. : 533-550

Informa Healthcare

Access to resources Recommend Favorite